We are live on ! Find out more
OMED

OncoMed Pharmaceuticals, Inc.
OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

Back to rankings

87 hedge funds and large institutions have $175M invested in OncoMed Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 18

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

5% more funds holding

Funds holding: 83 → 87 (+4)

26% less capital invested

Capital invested by funds: $235M → $175M (-$60.1M)

41% less call options, than puts

Call options by funds: $1.86M | Put options by funds: $3.13M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
87
Holders Change
+4
Holders Change %
+4.82%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
11
Increased
37
Reduced
18
Closed
7
Calls
$1.86M
Puts
$3.13M
Net Calls
-$1.27M
Net Calls Change
-$1.36M

Top Buyers

Rank Fund Capital Flow
1
DGI
Disciplined Growth Investors
Minnesota
+$6.22M
2
Wells Fargo
Wells Fargo
California
+$6.19M
3
Millennium Management
Millennium Management
New York
+$2.41M
4
BI
BVF Inc
California
+$2.23M
5
Prudential Financial
Prudential Financial
New Jersey
+$1.8M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$25.3M
2
JP Morgan Chase
JP Morgan Chase
New York
-$2.53M
3
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management
Japan
-$1.57M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
-$1.32M
5
N
Nuveen
North Carolina
-$687K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.5M -$40.3K -2,008 -2%
Prudential Financial
27
Prudential Financial
New Jersey
$1.49M +$1.8M +89,811 New
TC
28
TFS Capital
Pennsylvania
$1.37M +$968K +48,295 +140%
CS
29
Credit Suisse
Switzerland
$1.37M -$561K -27,985 -25%
VAM
30
Visium Asset Management
New York
$1.25M +$1.51M +75,100 New
Renaissance Technologies
31
Renaissance Technologies
New York
$1.12M +$857K +42,758 +171%
QI
32
QS Investors
New York
$1.1M – – –
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.06M -$160K -7,979 -11%
BIM
34
BlackRock Investment Management
Delaware
$974K -$26.7K -1,334 -2%
BC
35
Birchview Capital
Vermont
$974K – – –
Deutsche Bank
36
Deutsche Bank
Germany
$969K +$125K +6,233 +12%
BAM
37
Brave Asset Management
New Jersey
$774K +$511K +25,500 +121%
HLA
38
Hamilton Lane Advisors
Pennsylvania
$729K – – –
Charles Schwab
39
Charles Schwab
California
$674K +$49.4K +2,465 +6%
PI
40
Putnam Investments
Massachusetts
$645K +$22.1K +1,101 +3%
TAM
41
Tocqueville Asset Management
New York
$595K -$108K -5,400 -13%
HCM
42
Hodges Capital Management
Texas
$581K +$200K +10,000 +40%
NFA
43
Nationwide Fund Advisors
Ohio
$575K +$476K +23,745 +217%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$511K -$2K -100 -0.3%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$487K +$245K +12,197 +71%
GT
46
Glenmede Trust
Pennsylvania
$476K – – –
Group One Trading
47
Group One Trading
Illinois
$452K +$546K +27,230 New
ProShare Advisors
48
ProShare Advisors
Maryland
$407K -$31.6K -1,576 -6%
TA
49
Teachers Advisors
New York
$403K – – –
PCM
50
Piermont Capital Management
Missouri
$373K – – –
1
2
3 4

OMED Hedge Fund Activity: Q3 2015 in Review

87 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in OncoMed Pharmaceuticals, Inc. (OMED) for Q3 2015, worth a combined $175M — down 26% from $235M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new OMED positions and 7 closed out — a net gain of 4 holders — while 37 added to existing stakes and 18 trimmed.

The largest buyer was Disciplined Growth Investors, opening a new position worth an estimated $6.22M. The largest seller was Sectoral Asset Management, cutting an estimated $25.3M.

  • 87 institutional investors held OncoMed Pharmaceuticals, Inc. (OMED) as of Q3 2015, up from 83 in Q2 2015.
  • Funds reported $175M of OncoMed Pharmaceuticals, Inc. stock for Q3 2015, down 26% quarter-over-quarter.
  • 11 funds opened new OncoMed Pharmaceuticals, Inc. positions in Q3 2015 and 7 closed out, a net change of +4 holders.
  • The largest OncoMed Pharmaceuticals, Inc. buyer in Q3 2015 was Disciplined Growth Investors, an estimated $6.22M added.
  • The largest OncoMed Pharmaceuticals, Inc. seller in Q3 2015 was Sectoral Asset Management, an estimated $25.3M sold.

Based on aggregated 13F filings for Q3 2015.